Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | the enzyme is induced by interleukin-4, IFNgamma, CD3, CD28, and concanavalin A | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression analysis | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
actinonin | IC50: 0.000075 mM, kidney enzyme | Homo sapiens | |
bestatin | inhibits enzyme activity and cell growth, e.g. of leukocytes, overview, IC50: 0.0004 mM, kidney enzyme | Homo sapiens | |
bradykinin | inhibition is enhanced by substance P | Homo sapiens | |
iodoacetamide | IC50: 0.098 mM, kidney enzyme | Homo sapiens | |
additional information | structural features of natural peptide hormone inhibitors, overview | Homo sapiens | |
morphiceptin | - |
Homo sapiens | |
PAQ-22 | IC50: 0.00029 mM, kidney enzyme | Homo sapiens | |
phebestin | IC50: 0.000015 mM, kidney enzyme | Homo sapiens | |
probestin | IC50: 0.000016 mM, kidney enzyme | Homo sapiens | |
puromycin | IC50: 0.0031 mM, kidney enzyme | Homo sapiens | |
ranatachykinin | - |
Homo sapiens | |
RB3014 | IC50: 0.000025 mM, kidney enzyme | Homo sapiens | |
Substance P | - |
Homo sapiens | |
substance P1-4 | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cell surface | ectoenzyme, the enzyme has an N-terminal membrane anchor | Homo sapiens | 9986 | - |
membrane | type II transmembrane protein expressed on the cell suface | Homo sapiens | 16020 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | zinc-metallopeptidase | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | mechanism of APN signaling, enzyme inhibition has anti-proliferative effect and causes strong immunosuppression both in vitro and in vivo including growth arrest, induction of immunosuppressive cytokines, e.g. TGF-beta1, reduced expression of inflammatory or T-cell stimulating cytokines, e.g. interleukin-2 and interleukin-12, and mosulation of T-cell signalling pathways, overview, catalytic mechanism, ligand binding structure, active site structure, dynamic opening and closing | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | - |
Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
B-cell leukemia cell | - |
Homo sapiens | - |
epithelial cell | - |
Homo sapiens | - |
granulocyte | - |
Homo sapiens | - |
H9 cell | - |
Homo sapiens | - |
intestine | - |
Homo sapiens | - |
K-562 cell | - |
Homo sapiens | - |
KARPAS-299 cell | - |
Homo sapiens | - |
kidney | - |
Homo sapiens | - |
leukocyte | - |
Homo sapiens | - |
macrophage | - |
Homo sapiens | - |
monocyte | - |
Homo sapiens | - |
additional information | wide tissue distribution, expression analysis, detailed overview | Homo sapiens | - |
myelocytic leukemia cell | - |
Homo sapiens | - |
P-12 cell | - |
Homo sapiens | - |
pericardial fluid | - |
Homo sapiens | - |
synovial fluid | - |
Homo sapiens | - |
T-lymphocyte | activated | Homo sapiens | - |
THP-1 cell | - |
Homo sapiens | - |
thymocyte | - |
Homo sapiens | - |
U-937 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-Ala-4-nitroanilide + H2O | - |
Homo sapiens | L-Ala + 4-nitroaniline | - |
? | |
additional information | mechanism of APN signaling, enzyme inhibition has anti-proliferative effect and causes strong immunosuppression both in vitro and in vivo including growth arrest, induction of immunosuppressive cytokines, e.g. TGF-beta1, reduced expression of inflammatory or T-cell stimulating cytokines, e.g. interleukin-2 and interleukin-12, and mosulation of T-cell signalling pathways, overview, catalytic mechanism, ligand binding structure, active site structure, dynamic opening and closing | Homo sapiens | ? | - |
? | |
additional information | enzyme inhibition causes strong immunosuppression both in vitro and in vivo | Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | monomer structure, three-dimensional sructure, and structure modelling using the crystal structure, dynamic opening and closing of the active site | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
alanyl-aminopeptidase | - |
Homo sapiens |
aminopeptidase N | - |
Homo sapiens |
APN | - |
Homo sapiens |
CD13 | - |
Homo sapiens |
mAAP | - |
Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00044 | - |
Substance P | - |
Homo sapiens | |
0.0094 | - |
bradykinin | - |
Homo sapiens | |
0.169 | - |
morphiceptin | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000015 | - |
IC50: 0.000015 mM, kidney enzyme | Homo sapiens | phebestin | |
0.000016 | - |
IC50: 0.000016 mM, kidney enzyme | Homo sapiens | probestin | |
0.000025 | - |
IC50: 0.000025 mM, kidney enzyme | Homo sapiens | RB3014 | |
0.000075 | - |
IC50: 0.000075 mM, kidney enzyme | Homo sapiens | actinonin | |
0.00029 | - |
IC50: 0.00029 mM, kidney enzyme | Homo sapiens | PAQ-22 | |
0.0004 | - |
inhibits enzyme activity and cell growth, e.g. of leukocytes, overview, IC50: 0.0004 mM, kidney enzyme | Homo sapiens | bestatin | |
0.0031 | - |
IC50: 0.0031 mM, kidney enzyme | Homo sapiens | puromycin | |
0.098 | - |
IC50: 0.098 mM, kidney enzyme | Homo sapiens | iodoacetamide |